Background information:
Between approximately 2005 and 2014, a company called Invitrogen (later Life Technologies, currently ThermoFisher) marketed special peptides for protein kinase assays. Kinase-catalyzed phosphorylation of these substrates is accompanied an increase in fluorescence intensity, because of a special Mg+2-chelating aminoacid ("Sox" or "cSx") built into each particular peptide sequence [1]. Some researchers who used this assay did publish the sequence of the given peptide. See for example Ref. [2] below, where the sequence of a peptide marketed by Invitrogen under the catalog name "Y12" was Ac-Glu-Glu-Glu-Glu-Tyr-Ile(cSx)-Ile-Val-NH2. Invitrogen, under a license from MIT, sold several dozen of these kinase substrates. There are quite a few scattered papers in the biochemical literature, but unfortunately not all of them list the detailed sequence of the peptide substrates.
Now the question:
Is there anyone who would have in their possession some type of a document (maybe an old Invitrogen product manual, technical note, or any other material) that would list the peptide sequence of each particular kinase substrate marketed by Invitrogen under the Omnia® trade mark? If so, could you please either post that document here, or just contact me directly via email? Thanks very much in advance for your time.
REFERENCES
[1] Shults, M. D., and Imperiali, B., "Versatile fluorescence probes of protein kinase activity", J. Am. Chem. Soc. 125 (2003) 14248-14249.
[2] Schwartz, P. A., Kuzmic, P., Solowiej, J., Bergqvist, S., Bolanos, B., Almaden, C., Nagata, A., Ryan, K., Feng, J., Dalvie, D., Kath, J., Xu, M., Wani, R., and Murray, B. W., "Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance", Proc. Natl. Acad. Sci. U.S.A. 111 (2014) 173–178.